在无对比增强人群中鉴别脑炎症与II级胶质瘤:基于常规MRI的影像组学分析
本研究纳入57例无对比增强患者(II级胶质瘤39例、炎症18例),分为主要队列44例和验证队列13例,从T1WI和T2WI提取影像组学特征建模。T2WI模型和联合模型诊断效能较好,主要队列AUC分别为0.980和0.988,验证队列分别为0.950和0.925,均高于两名放射科医师评估的AUC(0.661和0.722)。
要点
- 无对比增强的脑炎症与II级胶质瘤在常规MRI上表现相似,影像组学模型有助鉴别。
- T2WI模型和T1WI+T2WI联合模型诊断效能较好,验证队列AUC分别为0.950和0.925。
- 影像组学模型效能优于两名放射科医师评估(AUC 0.661和0.722)。
核心结论
- 基于常规MRI影像组学特征的模型有助鉴别脑炎症与II级胶质瘤,效能优于经验丰富的放射科医师,可能具有临床实用价值。
研究设计与样本
- 回顾性研究,共纳入57例无对比增强患者(II级胶质瘤39例、炎症18例),分为主要队列44例和验证队列13例,从T1WI和T2WI提取影像组学特征,采用两样本t检验和LASSO回归筛选特征并建模。
诊断标准与关键数值
- T1WI模型、T2WI模型和联合模型分别使用4、8和5个影像组学特征;T2WI模型主要队列AUC为0.980、验证队列AUC为0.950;联合模型主要队列AUC为0.988、验证队列AUC为0.925;放射科医师1和2评估的AUC分别为0.661和0.722。
临床应用与阅片要点
- 作者认为基于影像组学特征的模型有助鉴别炎症与II级胶质瘤,可能具有临床实用价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: In populations without contrast enhancement, the imaging features of atypical brain parenchyma inflammations can mimic those of grade II gliomas. The aim of this study was to assess the value of the conventional MR-based radiomics signature in differentiating brain inflammation from grade II glioma.
METHODS: Fifty-seven patients (39 patients with grade II glioma and 18 patients with inflammation) were divided into primary (n = 44) and validation cohorts (n = 13). Radiomics features were extracted from T1-weighted images (T1WI) and T2-weighted images (T2WI). Two-sample t-test and least absolute shrinkage and selection operator (LASSO) regression were adopted to select features and build radiomics signature models for discriminating inflammation from glioma. The predictive performance of the models was evaluated via area under the receiver operating characteristic curve (AUC) and compared with the radiologists' assessments.
RESULTS: Based on the primary cohort, we developed T1WI, T2WI and combination (T1WI + T2WI) models for differentiating inflammation from glioma with 4, 8, and 5 radiomics features, respectively. Among these models, T2WI and combination models achieved better diagnostic efficacy, with AUC of 0.980, 0.988 in primary cohort and that of 0.950, 0.925 in validation cohort, respectively. The AUCs of radiologist 1's and 2's assessments were 0.661 and 0.722, respectively.
CONCLUSION: The signature based on radiomics features helps to differentiate inflammation from grade II glioma and improved performance compared with experienced radiologists, which could potentially be useful in clinical practice.
引用
- Han Y, Yang Y, Shi ZS, et al. Distinguishing brain inflammation from grade II glioma in population without contrast enhancement: a radiomics analysis based on conventional MRI. Eur J Radiol. 2020. PMID: 33307462. doi:10.1016/j.ejrad.2020.109467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。